Are you new to ctDNA testing strategies? Fear not! With this walk-through, we will guide you through some high-level concepts to help orient yourself in the current clinical landscape.
Vessel Tutorial - Understanding liquid biopsy results is highly dependent on tumor fraction of the cell-free DNA sample. Without information about ctDNA content from plasma, variant allele frequencies and uninformative testing results are very difficult to interpret.
In this condensed tutorial, Vessel presents three real-world cases of patients with confirmed progressive disease in which liquid biopsy was used to identify actionable targets. The tutorial also includes a brief summary of the patient's history and the results of the liquid biopsy.
Vessel focuses on providing end-to-end consulting in molecular tumor profiling. We aim to bridge the gap between precision medicine and clinical application, and offer programs to help remove barriers to implementing these approaches.